Biochemical analysis reveals a pattern of disturbances similar to XLH with dominating hypophosphatemia, hyperphosphaturia, low concentration of 1,25(OH)2D, and elevated or “inadequately” normal concentration of FGF23. The gene discussed is FGF23; the disease is X-linked hypophosphatemia.